M
Milestone Pharmaceuticals
MIST
1.39000
USD
-0.05
(-3.47%)
مغلق
حجم التداول
1,836
الربح لكل سهم
0
العائد الربحي
0
P/E
-1
حجم السوق
76,441,826
العنوان: Milestone Pharmaceuticals
القطاع: Healthcare
الصناعة: Biotechnology
Milestone Pharmaceuticals Inc is a biopharmaceutical company dedicated to developing and commercializing etripamil for the treatment of cardiovascular indications. Etripamil is a calcium channel blocker developed as a rapid-onset nasal spray to be administered by the patient to terminate episodes of paroxysmal supraventricular tachycardia, or PSVT. The company has an ongoing Phase 2 clinical trial for patients with atrial fibrillation experiencing a rapid ventricular rate (AFib-RVR).